Why This Pot Stock Could Double!

Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) may be one of the Canada’s top pot stocks, but that doesn’t mean it’s one of the best investments cannabis investors can make today.

| More on:
potted green plant grows up in arrow shape

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

There are a lot of pot stocks for investors to choose from out there, but not all of them have the same potential. The Canadian pot market is steadily growing, but in terms of potential size, it is nowhere near its neighbour to the south. Even now, with 11 states having legalized cannabis, there’s much more opportunity for growth in the industry in the U.S. than there is in Canada.

And that’s why for investors who want to capitalize on that opportunity, U.S. pot stocks could be the most appealing options today. One stock in particular that I see as being a good buy and that could double in value is Trulieve Cannabis (CNSX:TRUL), which has a strong presence in the U.S. with dozens of dispensaries in Florida, and the company is expanding its presence across the country.

With more than US$100 million in sales for all of 2018 and US$44.5 million already in Q1, the company is quickly becoming one of the largest pot stocks in North America, and yet its market cap of just $1.5 billion does not reflect that.

Many cannabis companies in Canada have often traded at significant multiples to sales, sometimes well into three digits. And at less than 15 times its sales, Trulieve has a lot of room to rise and even double. With the potential for the company to expand and grow into other U.S. markets, it is a very intriguing buy given how strong its sales are today and how much more they could still grow.

The company is a much more appealing option today than a stock like Aurora Cannabis (TSX:ACB)(NYSE:ACB). Although it has brought key personnel on board, we haven’t seen any recent moves from the company that would give investors reason to get excited about the stock’s future. While it is growing sales and reaching more customers, there doesn’t appear to be the same opportunity for Aurora to grow the way there is for Trulieve.

With a much larger market cap of around $11 billion, for Aurora to double it would rival the size of Canopy Growth, which is doing much more these days in terms of growth and acquisitions. However, neither of the Canadian-based stocks look like good bets to double given how big they’ve already gotten.

Aurora’s strategy on focusing on other parts of the world is one that, as an investor, I would steer clear of since it will bring in lots of expenses; the markets outside North America are going to be very limited. The U.S. is where the biggest opportunity is, and I don’t see Aurora being in a good position to take advantage of it once it becomes available.

Bottom line

While there may be opportunities for Aurora and other pot stocks to rise, especially with edibles on the way in Canada, for investors that want to maximize their returns, those stocks with exposure to the U.S. market will have the best odds of rising rapidly in value.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Fire & Flower: A Small Pot Stock Poised for Strong Growth

Fire & Flower is a cannabis retailer well-positioned for growth thanks to its digital and delivery initiatives.

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Is Sinking This Week

Starting another round of capital raising has hurt investor sentiments, and the Canadian cannabis giant’s performance on the stock market…

Read more »

edit Jars of marijuana
Cannabis Stocks

Why Canopy Growth (TSX:WEED) Stock Plunged 19% Last Week

Canopy Growth Corp. (TSX:WEED)(NASDAQ:CGC) stock has plunged after the release of its final fiscal 2022 results.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Aurora Cannabis (TSX:ACB) Stock Tanked 45% Last Week

There's no respite for Aurora Cannabis investors!

Read more »

Money growing in soil , Business success concept.
Cannabis Stocks

TFSA Investors: This Undervalued Gem Could Turn $6,000 Into $25,000

Here's why TFSA investors can hold undervalued growth stocks such as Verano in their portfolios right now.

Read more »